title: [Pulmonary hypertension due to left heart disease: recommendations of the Cologne Consensus Conference 2010].
abstract: The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension have been adopted for Germany. While the guidelines contain detailed recommendations regarding pulmonary arterial hypertension (PAH), they contain only a relatively short paragraph on other, much more frequent forms of PH such as PH due to left heart disease. Despite the lack of data, targeted PAH treatments are increasingly being used for PH associated with left heart disease. This development is of concern. On the other hand, PH is a frequent problem that is highly relevant for morbidity and mortality in patients with left heart disease, so that it may be speculated whether selected patients may benefit from targeted PH therapy. It that sense, the practical implementation of the European Guidelines in Germany requires the consideration of several specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to PH due to left heart disease. This commentary summarizes the results and recommendations of this working group.
authors.affiliation: Klinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Köln. stephan.rosenkranz@uk-koeln.de
authors.forename: S
authors.initials: S
authors.lastname: Rosenkranz
authors.forename: D
authors.initials: D
authors.lastname: Bonderman
authors.forename: M
authors.initials: M
authors.lastname: Buerke
authors.forename: R
authors.initials: R
authors.lastname: Felgendreher
authors.forename: H
authors.initials: H
authors.lastname: ten Freyhaus
authors.forename: E
authors.initials: E
authors.lastname: Grünig
authors.forename: F
authors.initials: F
authors.lastname: de Haan
authors.forename: C
authors.initials: C
authors.lastname: Hammerstingl
authors.forename: A
authors.initials: A
authors.lastname: Harreuter
authors.forename: W
authors.initials: W
authors.lastname: Hohenforst-Schmidt
authors.forename: I
authors.initials: I
authors.lastname: Kindermann
authors.forename: M
authors.initials: M
authors.lastname: Kindermann
authors.forename: F-X
authors.initials: FX
authors.lastname: Kleber
authors.forename: M
authors.initials: M
authors.lastname: Kuckeland
authors.forename: W M
authors.initials: WM
authors.lastname: Kübler
authors.forename: D
authors.initials: D
authors.lastname: Mertens
authors.forename: V
authors.initials: V
authors.lastname: Mitrovic
authors.forename: C
authors.initials: C
authors.lastname: Opitz
authors.forename: A
authors.initials: A
authors.lastname: Schmeisser
authors.forename: U
authors.initials: U
authors.lastname: Schulz
authors.forename: R
authors.initials: R
authors.lastname: Speich
authors.forename: W
authors.initials: W
authors.lastname: Zeh
authors.forename: J
authors.initials: J
authors.lastname: Weil
mesh_terms: D005858:Germany; D006333:Heart Failure / Q000150:complications* / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D016019:Survival Analysis; D018487:Ventricular Dysfunction, Left / Q000150:complications* / Q000175:diagnosis / Q000401:mortality / Q000628:therapy